WallStreetZenWallStreetZen

How to Buy Cadrenal Therapeutics Stock

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.

Cadrenal Therapeutics stock last closed at $0.42, down 0.93% from the previous day, and has decreased 70.56% in one year. It has underperformed other stocks in the Biotechnology industry by 0.47 percentage points. Cadrenal Therapeutics stock is currently +17.78% from its 52-week low of $0.36, and -86.5% from its 52-week high of $3.14.

At the moment, there are 16.01M shares of CVKD outstanding. The market cap of CVKD is $6.79M. In the past 24 hours, 54,777 CVKD shares were traded.

How to Buy Cadrenal Therapeutics Stock

Wondering how to invest in Cadrenal Therapeutics stock? Here's how.
  1. Choose where to buy Cadrenal Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Cadrenal Therapeutics stock.
  2. Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Deposit funds into your investment account: Pick your method of payment and add your details.
  4. Evaluate Cadrenal Therapeutics stock: The Cadrenal Therapeutics ticker symbol is CVKD. Is Cadrenal Therapeutics stock a good investment? Should you buy shares of CVKD? How do CVKD's underlying business fundamentals look? Do top analysts think Cadrenal Therapeutics is a good buy? Why has CVKD's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if CVKD is a good stock to buy).
  5. Place your CVKD purchase: Decide if you will purchase CVKD shares at the current market price or use a limit order to purchase CVKD stock at a particular price.
  6. Watch your investment in CVKD: Create a watchlist to important notifications about your new investment in Cadrenal Therapeutics shares.

Step 1: Choose where to buy Cadrenal Therapeutics stock

You will need a brokerage account in order to access the NASDAQ market and buy CVKD stock.

A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to global markets: From Technology to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've chosen the right brokerage, the next step is to fill out some personal details so you can buy CVKD today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to create your new brokerage account.
  1. Send your information by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have opened your account on one of the most highly reviewed stock apps, you need to deposit funds:

Watch the tutorial below if you need help transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Cadrenal Therapeutics stock

Once you have selected the best place to buy Cadrenal Therapeutics stock, it's absolutely critical to evaluate their stock before you invest, so you truly comprehend the risk and upside.

Overview of key CVKD info

CVKD Price
$0.42
1w %
-1.4%
1y %
-70.56%
5y %
N/A
P/E
-0.68x
P/B
0.88x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$8.36M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$6.79M
Next Earnings
N/A
Next Dividend
N/A

CVKD Due Diligence Checks

WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on CVKD's stock page.

Is CVKD stock overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge CVKD's intrinsic value.

Using relative valuations methods:

  • CVKD may be undervalued based on its P/B ratio of 0.88x, relative to Biotechnology industry P/B ratio of 5.8x

You can do additional valuation analysis on CVKD's stock here.

A quick look at CVKD Financials

Positive Financial Indicators:

  • There are more short-term assets than short-term liabilities on the CVKD balance sheet.
  • CVKD has $8.40M in cash and short term investments. This is sufficient to cover its annual cash burn of $3.53M.
  • CVKD has a low debt to equity ratio of 0.11.
  • There are more short-term assets than long-term liabilities on the CVKD balance sheet.
  • CVKD has cash burn of 3533577. It has enough cash and short-term investments to cover this for at least one year.

Is Cadrenal Therapeutics stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 2 Equities analysts who monitor CVKD, the consensus analyst rating on Cadrenal Therapeutics is a Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Cadrenal Therapeutics stock forecast page.

CVKD Technical Indicators

SMA10
0.41
SMA20
0.48
SMA50
0.59
SMA100
0.71
SMA200
0.72
MACD
-0.06
MACD Signal
-0.07
MACD Histogram
0.01
RSI
36.28
Stochastic %K
27.3
Stochastic %D
23.6
StochRSI %K
86.02
StochRSI %D
67.26

Are CVKD executives and large shareholders buying or selling the stock?

Over the past 12 months, executives and large shareholders at CVKD have bought more shares than they have sold.

John Raymond Murphy, Director of CVKD, was the latest CVKD insider to buy. They bought $1,841.61 worth of CVKD stock on Oct 5, 2023.

Research more about who owns CVKD stock here.

Does CVKD provide a stable income stream?

No, Cadrenal Therapeutics doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Place your CVKD purchase

There are two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are generally fine.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a given dollar amount limit, place a limit order.

Hit the Open Trade button and your broker will place the order.

If you need additional assistance investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Watch your investment in CVKD

Now that you own some CVKD shares, you'll want to keep up with your new investment.

Add CVKD to a watchlist to get notified of the latest news about your CVKD stock.

CVKD Feed

How to Buy Stock in Cadrenal Therapeutics

To reiterate, here are the 6 steps to buy Cadrenal Therapeutics stock:

  1. Choose where to buy Cadrenal Therapeutics stock
  2. Create your brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Cadrenal Therapeutics stock
  5. Place your CVKD purchase
  6. Watch your investment in CVKD

If you require a brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to watch your new investment in Cadrenal Therapeutics, create your watchlist below.

NASDAQ: CVKD
$0.42-0.00 (-0.93%)
Updated Apr 25, 2024
Open eToro Account
NASDAQ: CVKD
$0.42-0.00 (-0.93%)
Updated Apr 25, 2024
Open eToro Account

FAQ

How much does it cost to buy one Cadrenal Therapeutics share?

As of Apr 25, 2024, it costs $0.42 to buy one share of Cadrenal Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.21, you can buy 0.5 shares of CVKD.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cadrenal Therapeutics stock?

According to 2 Wall Street analysts who monitor Cadrenal Therapeutics, their consensus recommendation is to buy Cadrenal Therapeutics stock.

What is the best way to buy Cadrenal Therapeutics stock?

One way to place an order for Cadrenal Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.